MedTrace Logo

Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation

NCT02832089 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-07-14

No results posted yet for this study

Summary

Oral carvedilol administered in escalating doses in patients with atrial fibrillation among patients with AF with fast ventricular rate.

Conditions

Interventions

DRUG

oral carvedilol

oral carvedilol in escalating doses for reducing ventricular rate in AF patients

Sponsors & Collaborators

  • Andhra Medical College

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-12-31
Primary Completion
2002-03-31
Completion
2002-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02832089 on ClinicalTrials.gov